Smith & Nephew plc

SNN • Medical - Devices

$0.00

— 0.00 (0.00%)

EarningsLatest report: Dec 31, 2025

FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology

Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.

Market Cap

$12.82B

Growth

6.0%

Cash Flow

5/5

Trend

Stable

Evidence

Stable or improving margins · 10.1%Positive free cash flow · 1.97Consistent free cash flow · 5/5Manageable debt level · 0.63Healthy liquidity · 2.57

Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Mar 2, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00

Change0.00%

Market Cap$12.82B

52W Range29.08 - 38.79

Beta0.67

Gross Margin68.01%

Oper. Margin16.27%

Profit Margin10.14%

Debt/Eq0.63

Current Ratio2.57

Quick Ratio1.25

Revenue 5Y5.99%

Price$0.00

Change0.00%

Market Cap$12.82B

52W Range29.08 - 38.79

Beta0.67

Gross Margin68.01%

Oper. Margin16.27%

Profit Margin10.14%

Debt/Eq0.63

Current Ratio2.57

Quick Ratio1.25

Revenue 5Y5.99%

Target$30.93

Target Median$30.93

Target Range30.00 - 31.85

Volume1.38M

Avg Volume1.16M

EPS Surprise0.02

Investment DNA

How strong this company looks for long-term investors

out of 100

Business Quality

Margins, moat, returns

75/100

Financial Strength

Debt, cash, stability

82/100

Growth Potential

Revenue and expansion

81/100

Price Attractiveness

Cheap or expensive today

76/100

Why this score▼

Stable or improving margins · 10.1%Positive free cash flow · 1.97Consistent free cash flow · 5/5Manageable debt level · 0.63Healthy liquidity · 2.57

Analyst view

Analyst sentiment and price target

Analyst sentiment

No vote count available

Bullish

Hold

Bearish

Price Target

2026-06-25

Low

$30.00

Mean

$30.93

Median

$30.93

High

$31.85

Company Overview

IPO: 11/16/1999

Industry: Medical - Devices

P/B i: 2.69

Debt / Equity i: 0.63

Operating Margin: 16.27%

Net Margin: 10.14%

ROE i: -

ROIC: -

Financial Health

Score16 / 20

Debt / Equity: 0.63

Current Ratio: 2.57

Quick Ratio: 1.25

Status: Strong

🧾

No insider activity

No recent insider transactions available.

About the Company

Smith & Nephew plc

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Source - link

Peers

CNC COO FMS HOLX MEDP NBIX RPRX TEM THC ZBH

Size reflects market cap · color matches the chart line

1Y peer performance

Top performers + selected company

📰

No news available now

Check back later.

Earnings Surprises

Period	Estimate	Actual	Surprise
2026-03-02	1.16	1.18	0.02
2025-08-05	0.858	0.672	-0.186
2025-02-25	0.92	0.2251	-0.6949
2024-10-31	0.786	0.245	-0.541
2024-02-27	0.97	0.05212	-0.91788
2023-08-03	0.732	0.0985	-0.6335
2023-02-28	0.73	0.02644	-0.70356
2022-07-02	0.757	0.101	-0.656
2022-02-24	0.87	0.1817	-0.6883
2021-07-03	0.788	0.1165	-0.6715
2020-12-31	0.915	0.1976	-0.7174
2020-06-27	0.2913	0.057	-0.2343